Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients

Maintenance treatment after first-line chemotherapy for patients with metastatic colorectal cancer (mCRC) is a priority strategy. However, which medicine is chosen is controversial. This study aimed to determine the efficacy and safety of maintenance treatment with metronomic capecitabine vs observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Rui, Wang, Gang, Qiu, Lei, Liu, Bing, Yang, Fan, Zhang, Jingyu, Miao, Yongchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748176/
https://www.ncbi.nlm.nih.gov/pubmed/33371122
http://dx.doi.org/10.1097/MD.0000000000023719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748176/
https://www.ncbi.nlm.nih.gov/pubmed/33371122
http://dx.doi.org/10.1097/MD.0000000000023719

Ejemplares similares